NWRN fundamentals
NEWRON PHARMA N financial statements, including revenue, expenses, profit, and loss
The total revenue of NWRN for the last semiannual is 3.41 M CHF, and it's 36.98% lower compared to the previous semiannual. The net income of H2 23 is -8.88 M CHF.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CHF
TTM